Effects of the sodium-glucose cotransporter 2 (SGLT2) inhibitor velagliflozin, a new drug with therapeutic potential to treat diabetes in cats

M. Hoenig, M. Clark, D. J. Schaeffer, D. Reiche

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Effects of the sodium-glucose cotransporter 2 (SGLT2) inhibitor velagliflozin, a new drug with therapeutic potential to treat diabetes in cats'. Together they form a unique fingerprint.

Agriculture & Biology

Medicine & Life Sciences